|Address||Pekarska 53; 656 91 Brno; Czech Republic|
|Platforms||ATMP & Biological|
The International Clinical Research Center (FNUSA-ICRC) is an integral part of St. Anne’s University Hospital in Brno (FNUSA).
Thanks to its innovative approach, proactive teams, cutting-edge technologies and international collaboration, FNUSA-ICRC has become a multidisciplinary center of excellence in translational medical research.
FNUSA-ICRC focuses on finding new methods, technologies and medicaments for prevention, diagnostics and treatment of cardiovascular, neurological and selected oncological diseases and disorders. The FNUSA-ICRC infrastructure also comprises research facilities such as:
– The Clinical Pharmacology Unit (CPU) which is ISO 9001 certified for execution of pharmaceutical clinical evaluations phases I., II., III. and IV. The unit implements studies within the field of rheumatology, gastroenterology and oncology and also provides IIT clinical trials including designing and preparation of protocols for these trials.
– The Animal Centre (AC) that is focused on standardization of animals housing and experimental procedures according to the European and national legislation and regulatory compliances (e.g. FDA and MHRA).
– The Mass Spectrometry (MS) platform providing complete proteomics service. The main focus is concentrated on MS-based molecular imaging for the 2D and 3D spatial distribution of target molecules within intact cell or tissue structures.
– The Cell and Tissue Engineering Facility (CTEF-cGMP) represents a unit for Cell-based Medicinal Products (CBMPs) or Advanced Therapy Products (ATPs) including cell therapy and tissue engineered products. These products are manufactured from viable autologous, allogeneic or xenogeneic cells and they can also contain non-cellular components (chemical/biological compounds, matrices, scaffold etc.). All manufacturing and production control activities in CTEF are carried out in accordance with the principles of cGMP quality.